Chimerix Inc CMRX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
8.35UNCH (UNCH)
Volume
42,449
Close
8.35quote price arrow up+0.08 (+0.97%)
Volume
681,135
52 week range
2.22 - 11.57

...

Loading . . .
  • Open8.14
  • Day High8.38
  • Day Low8.09
  • Prev Close8.27
  • 52 Week High11.57
  • 52 Week High Date02/17/21
  • 52 Week Low2.22
  • 52 Week Low Date09/17/20

Key Stats

  • Market Cap719.85M
  • Shares Out86.21M
  • 10 Day Average Volume1.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.57
  • YTD % Change72.88

KEY STATS

  • Open8.14
  • Day High8.38
  • Day Low8.09
  • Prev Close8.27
  • 52 Week High11.57
  • 52 Week High Date02/17/21
  • 52 Week Low2.22
  • 52 Week Low Date09/17/20
  • Market Cap719.85M
  • Shares Out86.21M
  • 10 Day Average Volume1.01M
  • Dividend-
  • Dividend Yield-
  • Beta1.57
  • YTD % Change72.88

RATIOS/PROFITABILITY

  • EPS (TTM)-1.75
  • P/E (TTM)-4.78
  • Fwd P/E (NTM)-16.83
  • EBITDA (MRQ)-47.805M
  • ROE (MRQ)-111.22%
  • Revenue (MRQ)5.57M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-2,344.90%
  • Debt To Equity (MRQ)10.48%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Chimerix Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Chimerix, Inc is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. The Company has two clinical-stage product candidates, dociparstat sodium (DSTAT) and brincidofovir (BCV). DSTAT is a heparin derivative that enables dosing at higher concentrations to achieve anti-inflammatory. DSTAT is in development as a potential first-line therapy in acute myeloid leukemia (AML) and as a potential...
Martha Demski
Non-Executive Chairman
Michael Sherman
President
Michael Andriole
Chief Financial Officer
Address
2505 Meridian Pkwy Ste 100
Durham, NC
27713-2288
United States

Top Peers

SYMBOLLASTCHG%CHG
CRIS
Curis Inc
7.54-0.09-1.18%
KDMN
Kadmon Holdings Inc
3.99-0.19-4.55%
ORIC
Oric Pharmaceuticals Inc
19.98+0.50+2.57%
KDNY
Chinook Therapeutics Inc
15.18-0.82-5.12%
MRNS
Marinus Pharmaceuticals Inc
18.50+0.36+1.98%